Strs Ohio Palatin Technologies Inc Transaction History

Strs Ohio

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 23, 2020	SELL	$0.41 - $0.73 $321,399 - $572,247	-783,900 Closed	0 $0
Q4 2019 Jan 24, 2020	BUY	$0.75 - $0.89 $194,250 - $230,510	259,000 Added 49.34%	783,900 $613,000
Q2 2019 Jul 25, 2019	SELL	$0.98 - $1.64 $68,404 - $114,472	-69,800 Reduced 11.74%	524,900 $608,000
Q1 2019 Apr 19, 2019	SELL	$0.67 - $1.01 $42,411 - $63,933	-63,300 Reduced 9.62%	594,700 $582,000
Q4 2018 Jan 23, 2019	SELL	$0.63 - $1.0 $44,185 - $70,136	-70,136 Reduced 9.63%	658,000 $466,000
Q3 2018 Oct 19, 2018	SELL	$0.88 - $1.1 $36,400 - $45,500	-41,364 Reduced 5.38%	728,136 $726,000
Q2 2018 Aug 06, 2018	BUY	$0.91 - $1.45 $700,245 - $1.12 Million	769,500 New	769,500 $746,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $7.15M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.